A Year in Review and a Look to the Future: BTKi in CLL and MCL

Expert faculty discuss key trial data on the use of BTK inhibitors in CLL and MCL throughout the past year, as well as anticipated data from ASH 2023 and the current and potential impact on practice.

Om Podcasten

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.